Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
My GOAL is to be a Medical Science Liaison
Summary
In this episode, Jeremy McLemore shares his inspiring journey from pharmaceutical sales to becoming a Medical Science Liaison (MSL). Jeremy discusses his transition into the MSL role, detailing how he discovered the position and pursued it despite setbacks. He reflects on his experiences at Bristol Myers Squibb and AbbVie, highlighting the importance of networking, adaptability, and resilience in career progression. Jeremy also compares sales and MSL roles, offering insights into the unique challenges of each. He concludes with valuable advice for aspiring MSLs and shares his future goals.
Jeremy McLemore, Medical Science Liaison at AbbVie, discusses how his goal was to be an MSL and how he got there.
Jeremy shares….
How he approached his career from PharmD onward
The importance of being flexible and adaptable
Why it makes sense to consider a “starter” Industry role
How sales and field medical affairs differ (and how they are alike)
Medical Science Liaison, pharmaceutical sales, career progression, networking in medical field, MSL career advice
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO